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Dendritic cells (DCs) use all-trans retinoic acid (ATRA)
to promote characteristic intestinal responses, in-
cluding Foxp3 Treg conversion, lymphocyte gut
homing molecule expression, and IgA production.
How this ability to generate ATRA is conferred to DCs
in vivo remains largely unstudied. Here, we observed
that among DCs, retinaldehyde dehydrogenase
(ALDH1), which catalyzes the conversion of retinal to
ATRA, was preferentially expressed by small intestine
CD103 lamina propria (LP) DCs. Retinoids induced
LP CD103 DCs to generate ATRA via ALDH1 activity.
Either biliary or dietary retinoids were required to
confer ALDH activity to LP DCs in vivo. Cellular reti-
nol-binding protein II (CRBPII), a cytosolic retinoid
chaperone that directs enterocyte retinol and retinal
metabolism but is redundant to maintain serum reti-
nol, was required to confer ALDH activity to CD103
LP DCs. CRBPII expression was restricted to small
intestine epithelial cells, and ALDH activity in
CRBPII/ DCs was restored by transfer to a wild-type
recipient. CD103 LP DCs from CRBPII/mice had a
decreased capacity to promote IgA production. More-
over, CD103 DCs preferentially associated with the
small intestine epithelium and LP CD103DCALDH activ-
ity, and the ability to promote IgAproductionwas reduced
984in mice with impaired DC–epithelia associations. These
findings demonstrate in vivo roles for the expression of
epithelial CRBPII and lumenal retinoids to imprint local
gut DCs with an intestinal phenotype. (Am J Pathol 2012,
180:984–997; DOI: 10.1016/j.ajpath.2011.11.009)
The intestinal immune system is positioned at the inter-
face of the host with the environment, resulting in contin-
uous exposure to an array of substances derived from
food and the lumenal microbiota. In this precarious envi-
ronment, the immune system must both protect from in-
fection and avoid the untoward outcomes of overly exu-
berant or inappropriate responses. Dendritic cells (DCs)
are critical in initiating and shaping adaptive immunity,
and accordingly play a key role in properly guiding mu-
cosal immune responses.
Through the release of the biologically active vitamin A
metabolite all-trans retinoic acid (ATRA), DCs induce the
expression of gut homing molecules on responding lym-
phocytes, promote the conversion of naive T cells into
Foxp3-expressing Tregs, and promote the development
of IgA-producing plasma cells.1–8 These outcomes are
characteristic of homeostatic intestinal immune re-
sponses, and among DCs, CD103 DCs from the intes-
tine and associated lymphoid tissues have the ability to
provide ATRA and are the most efficient at promoting
these homeostatic outcomes.1,9,10 Understanding how
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has been the focus of much attention.
ATRA is unstable, and most studies indicate that DCs
supplying ATRA have the capacity to generate ATRA
from the stable parent compound, retinol. The conversion
of retinol to ATRA occurs by a two-step process in which
retinol is reversibly converted to retinal via alcohol dehy-
drogenases (ADHs) and subsequently irreversibly con-
verted to ATRA via cytosolic retinaldehyde dehydroge-
nase family members (RALDHs, also referred to as
ALDH1). Although ADHs are widely expressed by multi-
ple cell types, ALDH1 expression is more restricted and
therefore is viewed as a key component defining the
ability of cell types, including DCs, to generate ATRA. In
vitro studies revealed granulocyte-macrophage colony-
stimulating factor (GM-CSF), IL-4, and ATRA as factors
inducing ALDH1 expression in DCs.11–13 In addition,
ALDH1 expression is reduced in DCs from vitamin A–
deficient (VAD) mice,12 further supporting the role of
ATRA in this process. Observations that ALDH1 expres-
sion in these DCs can be rescued by supplying a vitamin
A–sufficient diet,12,14 and in vitro studies demonstrating
that co-culture of bone marrow–derived DCs (BMDCs)
with epithelial cell lines induces DC ALDH1 expres-
sion,12,14,15 support an elegant model wherein lumenal
vitamin A acts as an environmental cue shaping the phe-
notype of DCs and their attendant responses. In this
model, locally elevated ATRA levels derived from epithe-
lial cell conversion of lumenal retinoids supply a signal,
inducing ALDH1 expression in DCs near the epithelium.
These DCs subsequently imprint ensuing immune re-
sponses with a phenotype characteristic of intestinal ho-
meostasis, thus responding to this intestine-specific en-
vironmental cue. Despite these supporting findings, in
vivo confirmation and dissection of this model, which
implies a role for lumenal retinoids, epithelial-derived
ATRA, and DC–epithelial cell associations, has been dif-
ficult, in part due to the complexities of vitamin A biology
limiting interpretations of the relevant retinoid source.
The essential nutrient vitamin A, or retinoids, are a
group of compounds found in food of animal origin as an
ester, primarily retinyl palmitate, or in foods of plant origin
as a provitamin, including -carotene.16,17 Within the in-
testinal lumen, dietary retinyl esters are hydrolyzed into
retinol and absorbed by epithelial cells, whereas -caro-
tene is absorbed directly by enterocytes and subse-
quently converted to retinol. Within enterocytes, retinol is
esterified with long chain fatty acids, packaged into chy-
lomicrons, and transported to the liver for storage within
hepatic stellate cells, which contain a several-month sup-
ply of vitamin A. In addition epithelial cells have ALDH1
activity, and can generate ATRA from retinol via retinal.18
Due to the instability of the hormonally active retinoids
ATRA and 9-cis retinoic acid, retinol serves as both a
parent compound and as a means to distribute highly
unstable active retinoids. Thus, homeostasis is regulated
at the level of serum retinol levels maintained by the
release of hepatic stores, which are converted to biolog-
ically active retinoids within target tissues. In addition to
the serum, hepatic retinoids are also released in the
bile19,20 and in vitro studies have demonstrated that bilecan induce ALDH1 expression in BMDCs and endow
them with the ability to induce expression of the gut
homing molecule CCR9 on responding lymphocytes.21
Therefore, at least three retinoid sources could serve to
generate ATRA and induce ALDH1 expression in DCs:
serum, which is present systemically, and bile and diet,
which are present within the intestinal lumen. Interpreting
the effects of vitamin A status manipulation on DC ALDH1
expression to gain insight into how DCs acquire this
property is confounded by these multiple sources of ret-
inoids and their coincident regulation. Thus, decreased
ALDH1 expression by DCs from VAD mice does not
identify the relevant retinoid source for the induction of
ALDH1, because these mice have depleted hepatic
stores and lack both systemic (serum) and lumenal (bile
and dietary) retinoids. Likewise, observations of the res-
cue of DC ALDH1 expression in VAD mice with a vitamin
A–sufficient diet has ambiguous interpretations, because
lumenal dietary retinoids can be rapidly transferred to the
systemic pool.22
We investigated the in vivo role of lumenal retinoid
sources, epithelial-derived retinoids, and DC–epithelial
proximity in imprinting intestinal DCs. Here, we report that
lumenal retinoids from the diet or bile, as opposed to
systemic retinoids, were required to imprint intestinal DCs
with ALDH activity in vivo. This process was dependent on
intestinal epithelial cell expression of the cytosolic retinol
and retinal chaperone protein cellular retinol binding protein
II (CRBPII) and was disrupted in mice in which epithelial–DC
interactions were impaired. Together, these findings pro-
vide in vivo evidence for the role of epithelial-derived reti-
noids from lumenal sources in imprinting local gut DCs to
promote homeostatic intestinal immune responses.
Materials and Methods
Mice
C57BL/6 mice and B6SJL mice, a congenic strain carry-
ing the CD45.1 allele, were purchased from The Jackson
Laboratory (Bar Harbor, ME). CRBPII/ mice23 and
LTR/mice24 were bred for seven or more generations
onto the C57BL/6 background before use in experiments.
Animals were housed in a specific pathogen–free facility
and fed a diet containing 28 IU/g vitamin A unless other-
wise specified. Animals were 8 to 20 weeks of age at the
time of analysis. Bone marrow transplants were per-
formed as previously described.25 Animal procedures
and protocols were performed in accordance with the
institutional review board at Washington University
School of Medicine.
Isolation of Cellular Populations and Flow
Cytometry
Small intestines and colons were harvested, rinsed with
PBS, and Peyer’s patches (PP) were removed. Epithelial
cells and the associated hematopoietic cellular popula-
tions were released by three consecutive 15-minute in-
cubations in Hanks’ balanced salt solution medium
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mmol/L EDTA at 37°C in a rotating incubator. Isolation of
splenic and LP cellular populations was performed as
previously described.26 Cellular suspensions were then
passed through a 70-m nylon filter, and the cells were
prepared for flow cytometric analysis or sorting. Staining
with 7-amino-actinomycin D (7-AAD) (eBioscience, San
Diego, CA) was used to distinguish live cellular popula-
tions. Antibodies used for flow cytometry include: anti-
mouse CD103 (BD Biosciences, clone M290), anti-
mouse CD4 (clone GK1.5), anti-mouse CD11c (clone
N418), anti-mouse CD45 (clone 30.F11), and anti-mouse
MHCII (clone M5/114.15.2; all from eBioscience, except
as noted). The Aldefluor assay (Stem Cell Technologies,
Vancouver, BC, Canada) to detect ALDH activity was
performed per the manufacturer’s recommendations. The
percentage of ALDH cells was determined by compar-
ison with a control population treated with the ALDH
inhibitor diethylaminobenzaldehyde (DEAB).
ATRA Reporter Assay
The Sil-15 cell line, an F9 teratocarcinoma cell line trans-
fected with a -galactosidase reporter construct driven
by tandem repeats of the retinoic acid response ele-
ment,27 was subcloned, and clone E5B6, which dis-
played optimal retinoid sensitivity was selected for use in
these studies (see Supplemental Figure S1 at http://
ajp.amjpathol.org). Cellular populations to be tested were
isolated and cultured overnight in RPMI medium contain-
ing 10% fetal calf serum, 5  105 mol/L 2-ME, 2 mmol/L
L-glutamine, 10 mmol/L HEPES, 50 U/mL penicillin, 50
g/mL streptomycin, and 1 mmol/L sodium pyruvate at
37°C 5% CO2 in the presence or absence of 1 mol/L
retinol or 200 nmol/L ATRA (Sigma-Aldrich, St. Louis,
MO). Cellular populations were washed three times in
PBS, and transferred to 96-well plates containing the 1 
105 Sil-15 subclone E5B6 cells in the presence or ab-
sence of 1 mol/L citral (MP Biomedicals, Solon, OH), an
ALDH inhibitor, and cultured at 37°C 5% CO2. Twenty-
four hours later, supernatants were removed, and the
presence of -galactosidase activity was assessed using
a -Galactosidase Assay (Pierce, Rockford, IL) per the
manufacturer’s recommendations. Concentrations of ex-
perimental samples in equivalents of ATRA were interpo-
lated from a standard curve constructed from known
concentrations of ATRA (Sigma-Aldrich). Culture with cit-
ral did not affect the ability of Sil-15 E5B6 cells to respond
to exogenous ATRA (data not shown).
In Vitro ALDH Induction
Cellular populations were isolated as above and cultured
overnight at 37°C 5% CO2 in retinoid-free X-VIVO 10 me-
dium (Lonza) containing 5  105 mol/L 2-ME, 2 mmol/L
L-glutamine, 10 mmol/L HEPES, 50 U/mL penicillin, 50
g/mL streptomycin, and 1 mmol/L sodium pyruvate at
37°C 5% CO2 in the presence of the indicated concen-
tration of ATRA. RNA was isolated from cellular popu-
lations and used for real-time quantitative PCR as de-
scribed below.Immunohistochemistry
Immunohistochemistry on frozen sections was performed
as previously described.28 Antibodies used for immuno-
histochemistry include: anti-CD11c (clone HL3, BD Bio-
science), anti-CD103 (clone M290, BD Bioscience), anti-
CD3 (clone 145-2C.11, eBioscience), and anti-CD49f
(clone GoH3, eBioscience). Pseudo-colored black and
white images were obtained with an Axioskop 2 micro-
scope using Axiovision software (Carl Zeiss MicroImag-
ing, Thornwood, NY). To enumerate the DCs associating
with the epithelium, or epithelial-associatedDCs,mid jejunal
sections of intestine from two or more LTR/ or wild-type
mice were stained for CD11c, CD3, and CD49f. Ten or
more random photographs of villus cross sections were
obtained, and the number of DCs (CD11c CD3 cells)
lying above or within the basement membrane, as deter-
mined by CD49f staining, per villus were counted.
In Vitro IgA Induction Assay
Flow cytometrically sorted LP DC subtypes were co-cul-
tured at a 1:1 ratio with flow cytometrically sorted splenic
CD19 IgM B cells in RPMI medium containing 10% fetal
calf serum, 5 105 mol/L 2-ME, 2 mmol/L L-glutamine, 10
mmol/L HEPES, 50 U/mL penicillin, 50 g/mL streptomycin,
and 1 mmol/L sodium pyruvate at 37°C 5% CO2 in the
presence of 5 g/mL anti-CD40 (Axxora, San Diego, CA)
and 100 nmol/L ATRA and 10 ng/mL IL-6 where indicated.
After 6 days of culture, the number of IgA-producing cells
and the concentration of IgA were measured by enzyme-
linked immunosorbent spot and enzyme-linked immunosor-
bent assay (ELISA) as previously described.29
IL-6 ELISA
Flow cytometrically sorted CD103 LP DCs from C57BL/6
and LTR/mice were cultured in the above medium and
stimulated with 5 g/mL anti-CD40 antibody for 72 hours.
Following stimulation, IL-6 was measured in culture super-
natants using an IL-6 ELISA (R and D Systems, Minneapo-
lis, MN) per the manufacturer’s recommendations.
Quantitative Real-Time PCR Assay
RNA was extracted from cellular populations isolated as
above, treated with DNase, and transcribed into cDNA
using Superscript II Reverse Transcriptase (Invitrogen,
Carlsbad, CA) according to the manufacturer’s recommen-
dations. Primers used for Real-time-PCR include: 18S for-
ward 5=-CGGCTACCACATCCAAGGAA-3= and reverse
5=-GCTGGAATTACCGCGGCT-3=, ALDH1A1 forward 5=-
GGGAAAGAGCCCTTGCATTGTGTT-3= and reverse 5=-
GCGACACAACATTGGCCTTGATGA-3=, ALDH1A2 forward
5=-ACCGTGTTCTCCAACGTCACTGAT-3= and reverse 5=-
TGCATTGCGGAGGATACCATG AGA-3=, ALDH1A3 forward
5=-TCAACAAGATAGCCTTCACCGGCT-3= and reverse 5=-
TTGAAGAACACTCCCTGGTGAGCA-3=, and CRBPII for-
ward 5=-GGGTGGAGTTTGACGAACACACAA-3= and
reverse 5=-TTTGAACACTTGTCGGCACACCTG-3=. The
absolute copy number of the target was calculated
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Bile Duct Ligation
Mice were transferred to cages containing vitamin A–free
bedding and placed on diet AIN-93M (Purina Test Diet,
Greenfield, IN) containing 0.0 IU/g (VAD diet) or 28 IU/g
(control diet) vitamin A. Seven days later, mice received
either a sham surgery or ligation of the common bile duct
proximal to the union with the pancreatic duct. Forty-eight
hours after surgery, LP DC populations were analyzed by
flow cytometry as described above.
Statistical Analysis
Data analysis using Student’s t-test or a one-way analysis
of variance was performed using GraphPad Prism
(GraphPad Software, San Diego, CA).
Results
ALDH Activity Is Enriched in the Small Intestine
LP and Is Largely Restricted to CD103 DCs
Intestinal DCs, including those from the PP, mesenteric
lymph node (MLN), and LP express ALDH1.1,4,12 To gain
insight into the environment within the intestine where
ALDH1 expression is the greatest and therefore the lo-
cation in which ALDH may be induced, we evaluated
ALDH activity using the Aldefluor assay11,12,21,31 (Stem
Cell Technologies, Vancouver, BC, Canada) in total cell
populations and DCs from small intestine immune com-
partments, colon, spleen, and peripheral lymph node. We
found that the small intestine LP had the largest popula-
tion of cells with ALDH activity and that ALDH activity was
progressively less in the PP, MLN, and peripheral lymph
node, which correlates with the distance of these cell
populations from the small intestine epithelium (Figure
1A). Furthermore, we observed that the majority of the
cell population with ALDH activity in the small intestine LP
was CD45, CD11c, MHCII, and CD103, corre-
sponding to the CD103 DC population (Figure 1B). In
addition, we observed that the percentage of CD103
DCs with ALDH activity was largest in the small intestine
LP (Figure 1C), indicating that the differences in the
ALDH populations between the examined compart-
ments was not solely due to differences in the size of the
CD103 LP DC populations within each compartment.
CD103 LP DCs Express ALDH1A2 and
Generate ATRA in an ALDH-Dependent
Manner in Response to Retinoids
Of the multiple mammalian ALDH family members, three
murine members, ALDH1A1, ALDH1A2, and ALDH1A3,
can efficiently use retinal as a substrate, and are there-
fore indicators of the ability to generate ATRA.32–34 Anti-
gen-presenting cells from the intestine have been shownto variously express these ALDH1 isoforms, with PP DCs
expressing ALDH1A1,2 MLN DCs and LP CD11chi
CD11bhi LP DCs expressing ALDH1A2,2,7,12 and LP mac-
rophages expressing both ALDH1A1 and ALDH1A2.35 To
evaluate which of the retinal-converting ALDH isoforms
CD103 LP DCs express, we performed real-time quan-
titative PCR on RNA from sorted small intestine LP DCs.
Small intestine LP DCs predominantly expressed the
ALDH1A2 family member, and consistent with the assays
Figure 1. ALDH activity is enriched in the small intestine LP and is largely
restricted to CD103 DCs. To assess which compartment contained the
largest population of cells with the ability to generate ATRA, and by exten-
sion, where this ATRA generating capacity may be imprinted, cellular pop-
ulations were isolated from intestinal and systemic compartments and eval-
uated for the presence of ALDH activity using the flow cytometric based
Aldefluor assay. A: The small intestine LP contained a substantially larger
population of ALDH cells when compared with all other intestinal and
non-intestinal compartments. B: Analysis of the LP ALDH cells revealed that
the majority of this population was CD45 MHCII CD11c CD103, con-
sistent with CD103 DCs. LP cellular populations treated with DEAB, an
ALDH inhibitor served as a control to set the gate for positive staining. C:
Among CD103 DCs, those from the small intestine LP were significantly
more likely to be ALDH, indicating the differences in the ALDH popula-
tions from each tissue are not solely due to differences in the size of the CD103
DC populations. Col, colonic LP; LN, peripheral lymph node; MLN, mesenteric
lymph node; PP, Peyer’s patch; SI, small intestine LP; Spl, spleen. n 2 in A and
C. Data in B are representative of 1 of 8 experiments. *P  0.05.of ALDH activity, this expression was greatest in CD103
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augmented ability to convert retinol into ATRA when com-
pared with splenic DCs.2 To assess the ability of small
intestine LP CD103 DCs to generate ATRA, we evalu-
ated the presence of ATRA in cultures of sorted LP
CD103 DC populations using a biological reporter as-
say.27 Consistent with the presence of ALDH activity, we
observed that CD103 LP DCs generate ATRA, and that
ATRA generation was enhanced when the CD103 DCs
were cultured with retinol, the upstream parent com-
pound of ATRA, and inhibited by the ALDH inhibitor citral
(Figure 2B). These findings both directly demonstrate the
ability of LP CD103 DCs to generate ATRA and indicate
that this capacity may be augmented by retinol or, more
likely, ATRA itself, because CD103 DCs can convert
retinol to ATRA via ALDH1. To evaluate these possibili-
ties, LP cellular populations were pretreated with retinol
or ATRA, washed extensively, and evaluated for ATRA
generation in the presence or absence of the ALDH in-
hibitor citral. Treatment with retinol or ATRA significantly
increased the generation of ATRA, and this was inhibited in
both conditions by citral (Figure 2C). However, treatment
with ATRA resulted in the generation of much more ATRA
than treatment with retinol. The difference between the
ATRA-treated and ATRA- and citral-treated cultures was
100 ng/mL, whereas in comparison, the difference be-
tween retinol-treated and retinol- and citral-treated cultures
was1 ng/mL, indicating that ATRA treatment greatly aug-
mented the ability to convert retinol to ATRA via ALDHactivity. In vitro culture with ATRA augmented ALDH1A2
mRNA expression (Figure 2D), indicating that inducing
ALDH1A2 at the transcriptional level is one way in which
ATRA augments its own production. Therefore, in LP DCs,
ATRA is both an end product and a stimulus for its own
generation.
Lumenal Retinoids from Bile or Diet Imprint LP
DCs with ALDH Activity
Multiple cellular populations throughout the body have
the ability to convert retinol to ATRA, including intestinal
epithelial cells and stromal cells in the peripheral lymph
nodes.12,18,36 Systemic vitamin A homeostasis is regu-
lated at the level of serum retinol, which is released from
hepatic stores. In the adult mouse, hepatic vitamin A
stores are sufficient to maintain serum retinol levels for
months in the absence of ingestion of vitamin A from the
diet. Although compartments throughout the body are
bathed in retinol derived from serum, only cellular popu-
lations located in the mucosa would be exposed to the
potentially elevated levels of retinoids from lumenal
sources, which include the diet and bile. To evaluate
whether diet and/or bile are the relevant source of reti-
noids for the induction of ALDH activity in LP DCs in vivo,
we placed adult mice on a vitamin A–deficient diet or a
control diet and performed a sham operation or ligation of
Figure 2. LP CD103 DCs express ALDH1A2 and generate
ATRA in response to exogenous retinoids. The murine ALDH
family members ALDH1A1, ALDH1A2, and ALDH1A3 have
the capacity to convert retinal to ATRA. To evaluate whether
LP DCs express ALDH1 and which ALDH1 family members
they express, RNA was isolated from CD103 and CD103
sorted LP DCs, and the expression of ALDH1 family mem-
bers was measured by quantitative real-time PCR. A: CD103
LP DCs expressed ALDH1A2 and to a lesser extent
ALDH1A3, whereas CD103 LP DCs expressed ALDH1A2
and ALDH1A3 at lower levels than CD103 LP DCs. Expres-
sion of ALDH1A1 was low in both CD103 and CD103 LP
DCs. B: To confirm the ability of CD103 DCs to release
ATRA, 2  105 sorted CD103 LP DCs were assayed for
ATRA release using a biological reporter assay as described
in Materials and Methods. Splenic B cells, which are not
known to produce ATRA, were used as a negative control.
CD103 LP DCs generated biologically active ATRA, and the
ATRA-generating capacity was enhanced by pretreatment
with 1 mol/L retinol, and inhibited by the ALDH inhibitor
citral, indicating that retinoids induced the generation of
ATRA via ALDH activity. C: To evaluate which retinoid,
retinol or its downstream metabolite ATRA, effectively in-
duced ATRA release, 5  105 LP cells were pretreated with
retinoids and evaluated for ATRA generation in the presence
or absence of citral using a biological reporter assay. Pre-
treatment with ATRA resulted in a dramatic increase in ATRA
release that was 99.9% suppressed by ALDH inhibition,
whereas pretreatment with retinol resulted in a significant
but less dramatic increase in ATRA release that was sup-
pressed by ALDH inhibition. D: Overnight culture of LP cells
in increasing doses of ATRA demonstrated that ATRA in-
duced ALDH1A2 mRNA expression, thus indicating that
ATRA induces its own generation via the induction of
ALDH1A2 expression. *P  0.05. Data are representative of
one of two experiments.the common bile duct to interrupt the flow of bile. Mice
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LP DCs with ALDH activity. In the absence of bile and/or
dietary vitamin A, there was a significant decrease in the
ALDH LP DC population (Figure 3A). There was a trend
toward a decrease in LP DC ALDH activity in all of the
treatment groups, as measured by the mean fluores-
cence intensity of ALDH staining (Figure 3B). BDL re-
sulted in a trend toward a decrease in the LP DC popu-
lation, and this decrease became significant when both
bile and dietary vitamin A were removed (Figure 3C).
Although dietary retinoids were slightly more effective at
inducing ALDH activity in LP DCs, these findings indicate
that lumenal retinoids from bile or diet play a role in
imprinting gut DCs in vivo, and suggest a role for bile and
dietary vitamin A in maintaining the LP DC population.
Epithelial Cellular Retinol Binding Protein II Plays
a Critical Role in Imprinting CD103 LP DCs
with ALDH Activity
Due to its hydrophobicity, intracellular retinol is bound to
carrier proteins, or cellular retinol binding proteins, within
the aqueous environment of the cytosol. In the adult small
intestine, CRBPII is expressed by absorptive villous en-
terocytes, but not by gut lymphoid tissue epithelium,37
and acts as an intracellular chaperone directing the me-
tabolism of its ligands, retinol and retinal. In vitro studies
of CRBPII overexpression in epithelial cell lines demon-
strate that CRBPII facilitates retinol uptake.38 However, in
vivo studies of CRBPII/ mice on a vitamin A–enriched
diet have shown that this role is redundant for the main-
tenance of normal serum retinol levels.23 Therefore, al-
though CRBPII is not necessary to maintain serum retinol
concentrations when vitamin A is plentiful in the diet, its
chaperone function to direct the metabolism of retinol
and retinal within the cytosol of villous epithelial cells
could increase local retinoid concentrations and play a
role imprinting local gut DCs. To evaluate the role of
CRBPII in imprinting LP DCs, we examined the ALDH
activity of LP cells and LP DCs isolated from CRBPII/
mice. We observed that ALDH activity was decreased in
LP cells from CRBPII/ mice (Figure 4A) and that this
correlated with decreased ALDH activity in the CD103
LP DCs and a decrease in the population of ALDH
CD103 LP DCs (Figure 4, B and C). In addition to the
small intestine epithelial cells, CRBPII expression hasbeen found in placental tissues and fetal liver23,39; how-
ever, its expression in DCs has not been evaluated. Con-
sistent with prior reports, we observed that CRBPII was
highly expressed by small intestine epithelial cells and
was undetectable in the small intestine LP and CD103
and CD103 LP DCs (Figure 4D). We observed low lev-
els of CRBPII expression in colonic epithelial cells (Figure
4D), consistent with earlier reports of inducible CRBPII
expression in a colonic epithelial cell line.40 To further
confirm the role of nonhematopoietic sources of CRBPII
in imprinting LP DCs, we performed bone marrow
transfers of wild-type or CRBPII/ bone marrow into
wild-type or CRBPII/ recipients using congenic
CD45.1 or CD45.2 markers to identify donor-derived
populations. Consistent with a role for nonhematopoi-
etic-, or epithelial-, derived CRPBII in imprinting ALDH
activity, we observed that ALDH activity was significantly
decreased in CRBPII/ recipients of wild-type bone mar-
row, but not in wild-type recipients of CRBPII/ bone mar-
row (Figure 4, E and F). We did not observe a difference in
the LP DC populations between any of the groups (Figure
4G). In the rat intestine, CRBPII was found to be expressed
in a proximal-to-distal gradient.37 We hypothesize that epi-
thelial CRBPII plays a critical role in imprinting ALDH activity
in intestinal DCs by providing a local elevation in ATRA, and
accordingly, we investigated the correlation between the
gradient of CRBPII expression and ALDH activity by LP
DCs. Consistent with earlier reports of a proximal-to-
distal gradient of CRBPII expression in the rat intestine,
we observed that CRBPII was expressed in a proximal-
to-distal gradient in the murine intestine and that this
expression correlated with the ALDH activity in LP DCs
(Figure 4, H and I).
CD103 LP DCs from CRBPII/ Mice Have an
Impaired Ability to Facilitate IgA Production
Intestinal DCs facilitate the generation of IgA-producing
plasma cells, and this process is mediated in part by
ATRA.4,5,7 Using an in vitro co-culture model, we evalu-
ated the ability of LP DCs from CRBPII/ mice to facili-
tate the generation of IgA-producing plasma cells from
naive B cells. Consistent with their elevated ALDH activ-
ity, we found that wild-type CD103 LP DCs were more
efficient at inducing IgA production when compared with
Figure 3. Lumenal retinoids from bile or diet imprint LP DCs
with ALDH activity. To evaluate the relevant source of retinoids
imprinting LP DCs with ALDH activity, we evaluated LP DC
ALDH activity in mice receiving a sham surgery or common bile
duct ligation (BDL) on vitamin A deficient (VAD) diets or con-
trol diets. A: Mice on the control diet receiving BDL, mice on a
VAD diet receiving a sham surgery, and mice on a VAD diet
receiving BDL had a significant decrease in the population of
ALDH  LP DCs. B: Removal of either biliary and/or dietary
retinoids resulted in a trend toward decreased LP DC ALDH
activity, as determined by the mean fluorescence intensity. C:
Removal of lumenal bile resulted in trend toward a decrease in
the LP DC population, which became significant when both
bile and dietary vitamin A were removed. *P  0.05. ns  not
significant. n 3 or more mice in each group for A and C, n
2 mice in each group for B. Data are representative of one of
two experiments. VAC, Vitamin A control.their CD103 LP DC counterparts (Figure 5, A and B).
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AJP March 2012, Vol. 180, No. 3Figure 4. Epithelial CRBPII plays a critical role in
imprinting CD103 LP DCs with ALDH activity.
A–C: To evaluate a role for CRBPII in imprinting
LP DCs, LP cellular populations were isolated from
wild-type and CRBPII/ mice and evaluated for
ALDH activity. CRBPII/ mice had a decrease in
the population of ALDH LP cells (A), which cor-
related with a decreased level of ALDH expression
in CD103 LP DCs from CRBPII/ mice and with
a decrease in the population of CD103 LP DCs
that are ALDH  (B and C). D: Quantitative real-
time polymerase chain reaction was used to define
the cellular population expressing CRBPII. CRBPII
was highly expressed by small intestine epithe-
lium, was expressed at low levels in the colonic
epithelium, and was undetectable in the small in-
testine LP and CD103 and CD103 LP DCs. E
andF: Bone marrow transfers confirmed the re-
quirement for CRBPII on nonhematopoietic cells
for the induction of ALDH activity on LP DCs, as
transfer of wild-type bone marrow into CRBPII/
mice resulted in a significant reduction in the pop-
ulation of ALDH LP DCs, whereas conversely,
transfer of CRBPII/ bone marrow into wild-type
recipients resulted in an ALDH LP DC population
that was equivalent to the transfer of wild-type
bone marrow into wild-type recipients. G: There
was no significant difference in the size of the LP
DC population between the groups of bone mar-
row recipients. H and I: Evaluation of the distri-
bution of epithelial CRBPII expression and LP DC
ALDH activity in four equivalent sections of small
intestine revealed a correlating proximal to distal
gradient of CRBPII expression and ALDH activity
in LP DCs. C epi, colon epithelial cells; NS, not
significant; SI, full-thickness small intestine; SI epi,
small intestine epithelial cells; SI LP, small intes-
tine LP. *P  0.05. n  4 for data in A–C, H, and
I, n  3 for data in E–G; data are representative of
one of two experiments in D.
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ity seen in CD103 LP DCs from CRBPII/ mice, we
observed that these DCs had an impaired ability to facilitate
IgA production from naive B cells (Figure 5, A and B).
Interestingly, CD103 LP DCs from CRBPII/mice had an
increased capacity to support IgA production when com-
pared with their wild-type counterparts; however, this re-
mained well below the capacity of wild-type CD103 LP
DCs to support IgA production (Figure 5, A and B).
LP DCs from Mice with Impaired Epithelial Cell–
DC Associations Have Reduced ALDH Activity
The above findings implicate an important role for local or
mucosal/epithelial-derived retinoids in imprinting ALDH
activity in LP DCs. The basement membrane of the villous
epithelium is invested with pores through which phago-
cytic cells protrude.41,42 Furthermore, immunohistochem-
ical studies have demonstrated the presence of dendritic
cells closely associated with intestinal epithelial cells in
the small intestine,43,44 and that DCs are released with
the isolation of small intestine epithelial cells.45,46 To
better assess the characteristics of the DCs released
with the small intestine epithelial cells, and therefore the
DCs that might be imprinted by epithelial cells, we com-
pared the populations of cells released with the non–PP-
bearing small intestine. Consistent with prior observa-
tions, we found that CD45 CD11c MHCII cells, or
DCs, were present in the released epithelial cell popula-
tions (Figure 6A).45,46 This DC population could be di-
vided into a CD103 and CD103 population, which had
low expression of CD4 (Figure 6A). Both the CD103 and
CD103 population expressed CD11b, consistent with
the phenotype of the majority of LP DCs (Figure 6A).45,47
Intraepithelial T lymphocytes can also express CD11c.48
By immunohistochemistry, we observed that DCs
(CD11c CD3) associated with the epithelium above
or within the basement membrane border (Figure 6B).
Furthermore, evaluating intestines from Rag/ mice,
which lack T lymphocytes and simplify the immunohisto-
chemical staining strategy, we observed that some of
these DCs were CD103, consistent with the ALDH-ex-
pressing population (Figure 6B). The number of DCs
released with the epithelium was greatest with the sec-
ond fraction of isolated epithelium and outnumbered all ofthe DCs released with the PP follicle-associated epithe-
lium by 10-fold (Figure 6C). We observed that the colonic
epithelium contained very few DCs (Figure 6C). Consis-
tent with prior observations, the EDTA treatments did not
disrupt the villous architecture49,50 (see Supplemental
Figure S2 at http://ajp.amjpathol.org). The CD103 DCs
were released more easily by the EDTA treatments as
evidenced by their prominence in the first EDTA treat-
ment, suggesting they may be more closely associated
with the small intestine epithelium (Figure 6D). These
observations demonstrate that DCs associating with the
small intestine epithelium can have the same phenotype
as the DCs imprinted with ALDH activity.
The lymphotoxin  receptor (LTR) is a tumor necrosis
receptor superfamily member whose ligation on nonhe-
matopoietic cells results in the production of multiple
chemokines.51 The LTR is expressed on intestinal epi-
thelial cells,52 and epithelial expression of the LTR plays
an important role in recruiting leukocytes to the intes-
tine.53 We evaluated a role for the LTR in recruiting DCs
to associate with the epithelium by assessing the popu-
lation of DCs released with the isolation of intestinal epi-
thelial cells from LTR/ mice. We found that LTR/
mice had a diminished population of DCs released with
the epithelium (Figure 7A). Using immunohistochemistry
to assess the population of DCs (CD11c CD3) lying
above the basement membrane, demarcated by CD49f
staining, we observed a similar decrease in the DC pop-
ulation in the intestines of LTR/ mice (Figure 7B). We
also observed a corresponding decrease in the population
of LP cells with ALDH activity and accordingly a decrease in
the percentage of CD103 LP DCs with ALDH activity in the
intestines of LTR/ mice (Figure 7, C–E).
CD103 LP DCs from LTR/ Mice Have an
Impaired Ability to Facilitate IgA Production
ATRA produced by dendritic cells plays a role promoting
the development of IgA-producing plasma cells.5 To
evaluate the ability of LP DCs from LTR/ mice, which
have decreased ALDH activity, to facilitate the produc-
tion of IgA, we cultured sorted CD103 LP DCs with naive
B cells and evaluated the development of IgA-producing
plasma cells and IgA production as described above. We
Figure 5. CD103 LP DCs from CRBPII/ mice have an
impaired ability to facilitate IgA production. To assess for a
defect in CD103 LP DCs from CRBPII/ mice related to
their reduced ALDH activity, CD103 and CD103 LP DCs
from CRBPII/ mice and wild-type mice were isolated and
cultured with naive B cells and evaluated for the develop-
ment of IgA-producing plasma cells by enzyme-linked im-
munosorbent spot (A) and IgA production by ELISA (B) as
described in Materials and Methods. CD103 LP DCs from
wild-type mice had an augmented capacity to facilitate IgA
production, whereas CD103 LP DCs from CRBPII/ mice
were less effective at facilitating IgA production and were
comparable to the CD103 population. *P  0.05. Data are
representative of one of two experiments.observed that, consistent with their decreased ALDH ac-
second
ars in D
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ished capacity to promote the development of IgA-pro-
ducing plasma cells, and IgA production (Figure 8, A and
B). IL-6 production by intestinal DCs has been shown to
promote IgA production, and the addition of exogenous
IL-6 and ATRA to co-cultures of nonintestinal DCs and B
cells has been shown to facilitate IgA production equiv-
alent to that seen in co-cultures with intestinal DCs.5,54,55
We observed that LTR/ LP DCs were deficient in IL-6
production (Figure 8C) and that the addition of exogenous
ATRA and IL-6 could not restore their ability to promote IgA
production (Figure 8D). These observations indicate that LP
DCs from LTR/ mice have defects related to an intesti-
nal phenotype, ALDH activity, as well as other defects that
cannot be rescued by exogenous IL-6.
Discussion
The intestinal immune system uses a variety of strategies to
guard against infection and avoid overly exuberant immune
Figure 6. CD103 DCs associate with the small intestine epithelium. Flow cy
associating with the epithelial compartment. A: Gating on the live (7AAD) c
presence of CD45 CD11c MHCII cells that were predominantly CD103
were CD11b, consistent with the cell surface phenotype of the majority of
successive EDTA incubations revealed the majority of DCs were isolated in
incubation was dramatically decreased (100-fold). By comparison, the num
incubations combined was 10-fold less, and the number of DCs released from
patch–bearing small intestine epithelium. C: CD103 DCs were significantly
istry on frozen sections from intestines of wild-type mice confirmed the pres
as identified by CD49f staining, an integrin expressed on the basolateral surfac
strategy, staining was performed on intestines from Rag/ mice, lacking T
that some of the DCs observed to be lying above the small intestine baseme
by the presence of CD11c staining and lack of CD3 in wild-type mice or
(CD3) T lymphocyte in wild-type mice. 1  first EDTA incubation, 2 
representative of one of six experiments. n  3 for data in B and C. Scale bresponses, including the production of IgA antibodies toprevent lumenal organisms from breaching the epithelial
barrier,56 the development of Foxp3 regulatory T cells to
control immune responses,57 and the selective homing of
responding lymphocytes to the mucosal surfaces to lo-
calize appropriate immune responses.58,59 Recent work
has shown that DCs play a role in generating each of
these characteristic, or “homeostatic,” intestinal immune
responses, in part through the generation of the biologi-
cally active vitamin A metabolite ATRA,1–8 and that this
property is enhanced in a subset of DCs from the intes-
tine.5,6,9,59 Consequently, understanding how this ATRA-
generating capacity is bestowed on a subset of DCs has
been the focal point of multiple studies.
Vitamin A is an essential nutrient supplied through the
diet, and following the above discoveries of the effects of
DC-derived ATRA in guiding immune responses, it has
been intriguing to postulate that sources of vitamin A
specific to the intestine act as a cue to “inform” DCs of
their surroundings and direct their outcomes. However,
investigating this model in vivo has been complicated
and immunohistochemistry were used to evaluate the phenotype of the DCs
opulation released with epithelial cells by treatment with EDTA revealed the
03 CD4lo. Both the CD103 and CD103 DCs isolated with the epithelium
B: Enumeration of the DCs isolated from the Peyer’s patch–free intestine by
ond EDTA incubation, and that the number of DCs isolated with the third
Cs released from the Peyer’s patch follicle-associated epithelium in all three
lonic epithelium was 100-fold less, than that released from the non-Peyer’s
d in the population isolated with the first incubation. D: Immunohistochem-
DCs (CD11c CD3) cells lying within or above the basement membrane
small intestine epithelial cells. To simplify the immunohistochemical staining
onsistent with the flow cytometry findings, immunohistochemistry revealed
rane were CD103. IC, isotype control. Arrows denote DCs as determined
1c staining in Rag/ mice. Arrowheads denote a CD11c intraepithelial
EDTA incubation, 3  third EDTA incubation, *P  0.05. Data in A are
: 50 m.tometry
ellular p
or CD1
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the sec
ber of D
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the release of hepatic stores to maintain serum retinol
levels, to which all DCs are exposed.
ATRA is generated from the stable parent compound
retinol at target sites by the sequential actions of ADHs,
reversibly converting retinol to retinal, and ALDH1 irre-
versibly converting retinal to ATRA. Because ALDH is
expressed more selectively, its expression and activity
are viewed as a key phenotypic component of cellular
populations having the ability to generate ATRA. In ac-
cordance with this, studies have shown that intestinal
DCs can express ALDH1 family members,2,7,12,35 and
that the above intestinal-type responses mediated by
DCs can be inhibited by ALDH inhibitors or retinoic acid
receptor antagonists.1,2,4 In contrast to this, it has also
been reported that in vitro–derived DCs can act as
sources of biologically active ATRA for short periods in
the presence of an ALDH inhibitor.60
Studies investigating how DCs acquire ATRA-generat-
ing capacity have largely followed two approaches that
include using in vitro models to induce ALDH expression
and activity in BMDCs or the manipulation of vitamin A
status through the generation of VADmice. In vitro studies
identified GM-CSF, IL-4, and ATRA as factors inducingALDH expression.11–13 Studies also support toll-like re-
ceptor (TLR) activation enhancing ALDH expression by
DCs11,61,62; however, this may not be a strict requirement
because ALDH activity was maintained in MLN DCs in
which the TLR signaling pathways were disrupted.12 Co-
culture of BMDCs with an intestinal epithelial cell line
induced the expression of CD103 on the DCs and en-
dowed the DCs with an increased capacity to generate
Foxp3 T-regulatory cells and control colitis; this BMDC
transformation was mediated in part by ATRA.14 Addi-
tionally, in vivo studies of VAD mice support the role of
retinoids inducing ALDH expression by DCs, because
MLN DCs from VAD mice have decreased ALDH activity
and ALDH1A2 expression, which could be reversed by
resuming a vitamin A–containing diet.12,13,21 However, in
the VAD animal, dietary-derived retinoids bypass esteri-
fication and storage in the hepatic pool and are rapidly
shunted to the systemic pool to maintain vitamin A ho-
meostasis.22 Therefore, although supplementing VAD
mice with dietary vitamin A reversed the defect in ALDH
expression by intestinal DCs, consistent with a role for
vitamin A inducing ALDH expression,12 interpreting this
observation to support a role for lumenal retinoids as
igure 7. Epithelial–DC associations are disrupted in the absence of
e LTR, and ALDH activity is diminished in LP CD103 DCs from
TR/ mice. The epithelial compartment from wild-type and
TR/ mice was isolated as described in Materials and Methods
nd evaluated by flow cytometry for the presence of DCs. A: Flow
ytometry revealed that LTR/ mice had a significantly decreased
opulation of DCs released with the epithelium. B: Immunohisto-
hemical staining revealed a similar decrease in the epithelial DC
opulation defined as CD11c CD3 cells lying above the CD49f
mall intestine basement membrane.C–E: The decreased population
f DCs associated with the epithelium correlated with a decreased
opulation of ALDH LP cells (C and D) and a decrease in the
ercentage of CD103 LP DCs that were ALDH (E). EC, epithelial
ompartment. *P 0.05. n 4 mice in each group for data in A, and
–E. Data in B are representative of one of two replicates performed
s described in Materials and Methods.F
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narrow time window and dose effect with which ATRA
can induce ALDH activity in DCs,13 such that in vitro
models may not reflect events in vivo.
Other observations suggest bile as a source of lume-
nal, or local, retinoids inducing ALDH activity in intestinal
DCs.21 The concentration of retinol in bile is up to three
times that of serum.21 Related to this, bile can induce
ALDH activity in BMDCs, and intestinal DCs from mice
lacking dietary vitamin A for a short-term, 4 weeks, re-
tained ALDH activity.21 Although these observations are
consistent with the possibility that biliary retinoids imprint
ALDH activity in intestinal DCs, they do not rule out con-
tributions from serum-derived retinoids, which would be
unaffected in mice consuming a diet deficient in vitamin A
for the short term, nor do they account for the estimated
10-fold dilution of bile by intestinal secretions and diet
that could significantly lower the effective concentration
of biliary-derived lumenal retinoids.
Here, we have evaluated the in vivo requirements for
imprinting intestinal DCs with a “homeostatic” mucosal
phenotype. Prior studies have shown that DCs from the
PP, MLN, and LP displayed ALDH activity and expressed
ALDH1 family members; however, a systematic assess-
ment of which compartment had the largest populations
of DCs with ALDH activity within the same animals was
relatively uninvestigated. We observed that LP CD103
DCs displayed the highest ALDH activity and expressed
predominantly ALDH1A2. Moreover, we observed that
these DCs could generate biologically active ATRA, and
consistent with in vitro studies of BMDCs, we observed
that this capacity was enhanced by retinol, reduced by
ALDH inhibition, and markedly induced by ATRA itself.
Given that ATRA is inherently unstable, the above obser-
vations indicate that DCs receiving this signal would
need to be in close approximation to the ATRA source. To
determine the relative contributions of systemic (serum)
and lumenal (diet and bile) retinoid sources, we manip-
ulated lumenal retinoid sources for short periods of time
Figure 8. CD103 DCs from the LP of LTR/ mice have an impaired abil
To evaluate the ability of CD103 DCs from LTR/ mice to facilitate IgA
isolated and cultured with naïve B cells as described in Materials and Metho
development of IgA-producing plasma cells (A) and IgA production (B). C
addition of 100 nmol/L ATRA or 100 nmol/L ATRA and 10 ng/mL IL-6 did not
suggesting additional defects in this DC population. *P  0.05. Data are repand evaluated the effects on LP DC ALDH activity. Weobserved that both dietary and biliary retinoid sources
could imprint LP DCs, with dietary sources being some-
what more effective. Interestingly, there were differences
between loss of bile or dietary vitamin A on LP DCs, with
loss of bile more dramatically affecting the size of the total
LP DC population, and loss of dietary vitamin A having a
slightly greater effect on DC ALDH activity. This could be
explained in part by differences in the duration of each
manipulation, because mice were on a VAD diet for 7
days and had disruption of bile for 2 days. This could also
suggest that bile contains biologically active substances
not present in the diet that play a role in recruiting or
maintaining the LP DC population. In conjunction with our
above observations, these findings are indicative of a local
intestinal site where DCs become imprinted by lumenal
retinoids to confer homeostatic mucosal properties.
CRBPII is highly and selectively expressed by small
intestine villous epithelial cells, and serves as a chaper-
one directing the metabolism of its ligands, retinol and
retinal.37,63 In vitro studies demonstrated that CRBPII fa-
cilitates retinol uptake and processing by epithelial cells,
and the inference was that CRBPII played an important
role in total body vitamin A homeostasis by facilitating the
uptake and processing of dietary retinoids.40 Supporting
this assumption, jejunal segments from CRBPII/ mice
had a 50% reduction in retinol uptake at low retinol con-
centrations. However, at higher retinol concentrations,
there was no difference in retinol uptake between wild-
type and CRBPII/ intestines.23 CRBPII/ mice had no
overt phenotype with respect to growth, development, or
the maintenance of normal serum retinol levels while on a
vitamin A–enriched diet containing 25 IU retinyl ester/g,23
further suggesting a redundancy for CRBPII’s role in sys-
temic retinol homeostasis when dietary vitamin A is plen-
tiful. Although hepatic retinoid stores were reduced by
40% in CRBPII/ mice, the significance of this was
unclear because hepatic retinoid stores were far from
depleted, and serum retinol levels were maintained.23
Building on the above observations, we evaluated the
ilitate IgA production that cannot be rescued by exogenous ATRA and IL-6.
tion, CD103 and CD103 LP DCs from wild-type and LTR/ mice were
03 DCs from LTR/ mice displayed a diminished ability to facilitate the
 LP DCs from LTR/ mice had diminished production of IL-6. D: The
he ability of CD103 LP DCs from LTR/mice to promote IgA production,
tive of one of two experiments.ity to fac
produc
ds. CD1
: CD103LP DC population in CRBPII/ mice ingesting a vitamin
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potential effects due to the loss of epithelial retinoid up-
take and/or the loss of appropriate chaperoning of retinal
and retinol within epithelial cells for downstream metab-
olism, while maintaining normal serum retinol levels. LP
DCs from CRBPII/ mice had reduced ALDH activity. In
wild-type mice, CRBPII expression was restricted to the
epithelium of the small intestine, and importantly, LP DCs
did not express CRBPII. The defect in ALDH activity in LP
DCs from CRBPII/ mice could be rescued when they
were transferred to a CRBPII-sufficient recipient. When
wild-type LP DCs were transferred to a CRBPII/ recip-
ient, they displayed reduced ALDH activity. Moreover, we
observed a proximal-to-distal gradient of CRBPII expres-
sion and a proximal-to-distal gradient of LP DC ALDH
activity, which was also recently reported by others,62 fur-
ther strengthening the association of epithelial CRBPII in the
induction of LP DC ALDH activity. Consistent with prior
reports of ATRA generated by DCs facilitating IgA produc-
tion,5 we found that CD103 LP DCs from CRBPII/
mice were less effective at this process. Our current
understanding is that CD103 MLN DCs arise from the
migration of CD103 LP DCs.31 ALDH1A2 expression
and ALDH activity increase in MLN DCs from 3 weeks of
age to adulthood.12 Of note, this time course correlates
with changes in the expression of CRBPII in intestinal
epithelial cells, such that small intestinal enterocyte
CRBPII expression decreases after birth during the suck-
ling period and increases after weaning into adulthood,64
thus providing further support for a link between epithelial
cell CRBPII expression and ADLH expression and activity
in intestinal DCs. Somewhat in contradiction to our ob-
servations that ATRA was the more efficient retinoid in
inducing ALDH dependent ATRA generation by CD103
LP DCs, and our observation that ALDH activity in
CD103 LP DCs was diminished in CRBPII/ mice, in
vitro studies of mucosal scrapings from CRBPII/ mice
revealed no defect in their ability to generate ATRA when
supplied with retinal.65 However, with this assay, neither
wild-type nor CRBPII/ scrapings produced ATRA when
supplied with retinol.65 Earlier observations indicate that
intestinal epithelial CRBPII expression may play an im-
portant role facilitating lumenal retinoid uptake to main-
tain total body vitamin A levels when vitamin A is limiting
in the diet. Our observations demonstrate another impor-
tant role for epithelial CRBPII by facilitating the produc-
tion of an environmental cue to imprint LP DCs even when
dietary vitamin A is not limiting.
The instability of ATRA dictates that DCs would need to
be in close proximity to the source of ATRA for efficient
ALDH induction. The above findings and prior in vitro
studies support a role for epithelial cells in DC induction
of ALDH activity. Multiple observations suggest that a
subset of LP DCs are in close association with intestinal
epithelial cells and may contact epithelial cells via pores
in the basement membrane.41–46 We evaluated the phe-
notype of the DCs released with epithelial cells during
their isolation and similar to an earlier report,45 found
that the majority of these DCs were CD103, consistent
with the population that displays ALDH activity. We con-
sidered lymphoid tissues as alternative sources for theDCs released with the epithelium. However, we do not
favor this explanation because the DCs released with the
villous epithelium outnumber those released from the PP
follicle–associated epithelium by 10-fold, making this an
unlikely source for these DCs even if the Peyer’s patches
were to remain in place. Furthermore, the DCs released
with the epithelium have a cell surface phenotype that is
distinct from those of the solitary intestinal lymphoid tis-
sues,30 and the solitary intestinal lymphoid tissues remain
intact following the removal of the epithelial cells (see
Supplemental Figure S2 at http://ajp.amjpathol.org).
LTR is expressed by nonhematopoietic cells, includ-
ing intestinal epithelial cells,52 and directs the production
of multiple chemokines.51 Intestinal epithelial cell–spe-
cific expression of the LTR plays an important role in
recruiting leukocytes to the intestine,53 and accordingly,
we evaluated the population of DCs associating with the
epithelium in LTR/mice and found that LTR/mice
had a diminished population of DCs released with the
epithelium. Our above findings demonstrate that an epi-
thelial-specific retinoid pathway imprints LP DCs via the
unstable retinoid ATRA, and consistent with the require-
ment for close association of epithelial cells and DCs for
this process, ALDH activity was diminished in the
CD103 LP DCs from the LTR/ mice. Moreover, this
defect translated to a diminished ability of the CD103 LP
DCs from the LTR/ mice to promote IgA production.
Prior studies have shown that IL-6 produced by intestinal
DCs promotes IgA production,54,55 and that exogenous
IL-6 can allow nonintestinal DCs to facilitate IgA produc-
tion.5 Accordingly, we observed that LP DCs from
LTR/ mice had diminished IL-6 production, and that
exogenous IL-6 and ATRA were unable to restore their
ability to promote IgA production. Thus LTR/ LP DCs
have deficits related to an intestinal phenotype, ALDH
activity, which could be related to their inability to asso-
ciate with the epithelium, as well as deficits related to
other DC properties that cannot be overcome with exog-
enous IL-6 and ATRA. These additional defects could be
related to the well-documented absence of lymphoid tis-
sues in the LTR/ mice.24,66–68 Prior studies have
shown that LTR/ mice have diminished intestinal IgA
production, which has been linked to the lack of intestinal
lymphoid tissues, and altered lymphocyte homing be-
cause of defective chemokine production.24,25,66,69 Our
observations suggest additional defects in the intestinal
DCs from LTR/ mice. Although this could contribute
to the decreased IgA production seen in the LTR/
mice, this defect is likely overshadowed by the lack of
lymphoid tissues, which provide an environment for DC–
lymphocyte interactions.
It has long been appreciated that the intestinal immune
system has characteristics that are distinct from the sys-
temic immune system including the predominance of
IgA, the predominance of Foxp3 Tregs, and the specific
homing properties of lymphocytes. Recent work has
shown that these characteristic intestinal-type responses
are guided in part by ATRA generated by a subset of
DCs. Understanding how DCs are endowed with this
property has been the focus of multiple studies, whose
results suggest that vitamin A is an intestine-specific en-
996 McDonald et al
AJP March 2012, Vol. 180, No. 3vironmental cue imprinting these properties on DCs.
Here, we provide in vivo data supporting this model, and
evidence that CRBPII, an intestinal epithelial cell–specific
cytosolic retinol and retinal chaperone, plays an integral
role in transforming lumenal retinoids into a local cue to
imprint gut DCs with this intestinal phenotype.
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